LPCAT2 controls chemoresistance in colorectal cancer
Lipid droplets (LD) are now-well recognized as playing a role in cancer progression, however their potential role in chemoresistance remains largely unknown, particularly in colorectal cancer (CRC). We recently highlighted that LD accumulate in CRC cells under the control of lysophosphatidylcholine...
Main Authors: | Alexia Karen Cotte, Virginie Aires, François Ghiringhelli, Dominique Delmas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-05-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2018.1448245 |
Similar Items
-
Emergence of Lipid Droplets in the Mechanisms of Carcinogenesis and Therapeutic Responses
by: Dominique Delmas, et al.
Published: (2023-08-01) -
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
by: Lin T, et al.
Published: (2021-11-01) -
Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis
by: Vijay Kondreddy, et al.
Published: (2024-03-01) -
Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
by: Melanie Merkel, et al.
Published: (2023-08-01) -
Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer
by: Tianyi Zhao, et al.
Published: (2021-05-01)